DBV Technologies Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de DBV Technologies de 6.5% y 59.6%, respectivamente.
Información clave
6.5%
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Biotechs | 4.6% |
| Tasa de crecimiento de los ingresos | 59.6% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 25 Oct 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
DBV Technologies S.A.'s (EPA:DBV) 41% Share Price Surge Not Quite Adding Up
Oct 24
Analysts Just Made A Major Revision To Their DBV Technologies S.A. (EPA:DBV) Revenue Forecasts
Aug 04Risks To Shareholder Returns Are Elevated At These Prices For DBV Technologies S.A. (EPA:DBV)
Jun 14We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now
May 10DBV Technologies S.A. (EPA:DBV) Released Earnings Last Week And Analysts Lifted Their Price Target To €6.50
May 09Some DBV Technologies S.A. (EPA:DBV) Analysts Just Made A Major Cut To Next Year's Estimates
Mar 14DBV Technologies S.A. (EPA:DBV) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 10Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?
Dec 01Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?
Jun 23We're Hopeful That DBV Technologies (EPA:DBV) Will Use Its Cash Wisely
Mar 09Here's Why We're Not Too Worried About DBV Technologies' (EPA:DBV) Cash Burn Situation
Oct 04DBV Technologies S.A. (EPA:DBV) Shares Could Be 45% Below Their Intrinsic Value Estimate
Aug 06Here's Why DBV Technologies (EPA:DBV) Must Use Its Cash Wisely
Mar 14Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 6 | -124 | -183 | -119 | 1 |
| 12/31/2025 | 5 | -119 | -172 | -114 | 1 |
| 12/31/2024 | 5 | -128 | -160 | -110 | 2 |
| 9/30/2024 | 13 | -102 | -109 | -106 | N/A |
| 6/30/2024 | 14 | -88 | -105 | -103 | N/A |
| 3/31/2024 | 15 | -80 | -95 | -94 | N/A |
| 12/31/2023 | 16 | -73 | -80 | -80 | N/A |
| 9/30/2023 | 6 | -101 | -90 | -90 | N/A |
| 6/30/2023 | 5 | -101 | -91 | -90 | N/A |
| 3/31/2023 | 4 | -100 | -76 | -75 | N/A |
| 12/31/2022 | 5 | -96 | -56 | -56 | N/A |
| 9/30/2022 | 9 | -71 | -52 | -51 | N/A |
| 6/30/2022 | 8 | -77 | -55 | -53 | N/A |
| 3/31/2022 | 5 | -85 | -74 | -74 | N/A |
| 12/31/2021 | 6 | -98 | -109 | -108 | N/A |
| 9/30/2021 | 2 | -124 | -124 | -123 | N/A |
| 6/30/2021 | 4 | -131 | -144 | -142 | N/A |
| 3/31/2021 | 9 | -148 | -154 | -152 | N/A |
| 12/31/2020 | 11 | -160 | -168 | -166 | N/A |
| 9/30/2020 | 17 | -161 | -157 | -153 | N/A |
| 6/30/2020 | 16 | -171 | -156 | -151 | N/A |
| 3/31/2020 | 16 | -169 | -161 | -156 | N/A |
| 12/31/2019 | 15 | -172 | -154 | -148 | N/A |
| 9/30/2019 | 12 | -176 | -156 | -151 | N/A |
| 6/30/2019 | 13 | -198 | -176 | -169 | N/A |
| 3/31/2019 | 13 | -191 | -166 | -160 | N/A |
| 12/31/2018 | 13 | -190 | -162 | -157 | N/A |
| 9/30/2018 | 11 | -178 | -164 | -157 | N/A |
| 6/30/2018 | 11 | -172 | N/A | -145 | N/A |
| 3/31/2018 | 11 | -182 | N/A | -147 | N/A |
| 12/31/2017 | 12 | -177 | N/A | -137 | N/A |
| 9/30/2017 | 11 | -169 | N/A | -118 | N/A |
| 6/30/2017 | 11 | -157 | N/A | -97 | N/A |
| 3/31/2017 | 9 | -135 | N/A | -77 | N/A |
| 12/31/2016 | 8 | -121 | N/A | -63 | N/A |
| 9/30/2016 | 8 | -109 | N/A | -58 | N/A |
| 6/30/2016 | 8 | -88 | N/A | -49 | N/A |
| 3/31/2016 | 8 | -72 | N/A | -41 | N/A |
| 12/31/2015 | 7 | -49 | N/A | -29 | N/A |
| 9/30/2015 | 6 | -40 | N/A | -28 | N/A |
| 6/30/2015 | 6 | -30 | N/A | -25 | N/A |
| 3/31/2015 | 5 | -27 | N/A | -23 | N/A |
| 12/31/2014 | 6 | -29 | N/A | -25 | N/A |
| 9/30/2014 | 6 | -30 | N/A | -24 | N/A |
| 6/30/2014 | 7 | -32 | N/A | -25 | N/A |
| 3/31/2014 | 6 | -28 | N/A | -21 | N/A |
| 12/31/2013 | 5 | -27 | N/A | -18 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que DBV siga sin ser rentable en los próximos 3 años.
Beneficios vs. Mercado: Se prevé que DBV siga sin ser rentable en los próximos 3 años.
Beneficios de alto crecimiento: Se prevé que DBV siga sin ser rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (59.6% al año) de DBV crezcan más rápidamente que los del mercado French (5.6% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos (59.6% al año) de DBV crezcan más rápidamente que un 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de DBV se prevé que sea elevada dentro de 3 años.